tirzepatide cvot results Can Dual Incretin Receptor Agonists Exert Better Cardiovascular Protection than Selective GLP-1 Receptor Agonists? Highlights from SURPASS-CVOT | Diabetes Therapy What do topline data from

To minimize the side effects, healthcare providers typically adopt a gradual dosage increase over a few weeks

doi:10.1056/NEJMoa2206038 [5]4

Unravelling the effects of the environment and host genotype on the gut microbiome

Perhaps now theres a real chance that we can get our B12 injections made available over the counter and bring us into line with other countries around the world so that we in the UK arent left behind

Dahl D, Onishi Y, Norwood P, et al

This review aims to critically examine the interplay between sarcopenia and T2D, with a focus on underlying pathophysiological mechanisms, nutritional determinants, and clinical implications